Filing Details

Accession Number:
0001179110-12-016262
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-19 18:07:00
Reporting Period:
2012-11-15
Filing Date:
2012-11-19
Accepted Time:
2012-11-19 18:07:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158223 Affymax Inc AFFY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1344153 H Jeffrey Knapp C/O Affymax, Inc.
4001 Miranda Ave.
Palo Alto CA 94304
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-15 984 $6.23 14,109 No 4 M Direct
Common Stock Acquisiton 2012-11-15 1,099 $10.99 15,208 No 4 M Direct
Common Stock Acquisiton 2012-11-15 3,750 $18.84 18,958 No 4 M Direct
Common Stock Disposition 2012-11-15 5,833 $22.62 13,125 No 4 S Direct
Common Stock Acquisiton 2012-11-19 1,000 $21.74 14,125 No 4 M Direct
Common Stock Disposition 2012-11-19 1,000 $23.00 13,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-11-15 984 $0.00 984 $6.23
Common Stock Stock Option (Right to Buy) Disposition 2012-11-15 1,099 $0.00 1,099 $10.99
Common Stock Stock Option (Right to Buy) Disposition 2012-11-15 3,750 $0.00 3,750 $18.84
Common Stock Stock Option (Right to Buy) Disposition 2012-11-19 1,000 $0.00 1,000 $21.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,360 2020-07-21 No 4 M Direct
1,167 2019-01-14 No 4 M Direct
48,082 2016-07-27 No 4 M Direct
6,000 2017-12-17 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The shares were sold at prices ranging from $22.26 to $22.94. The reporting person will provide to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The award vests on a monthly basis in equal installments during the 48 month period beginning on July 22, 2010.
  4. The award vests on a monthly basis in equal installments during the 48 month period beginning on January 1, 2009.
  5. Fully vested.